|
|
||||||||
i does not alter
cardiac function or
-adrenergic sensitivity
1 Whitaker Cardiovascular Institute, Boston University School of Medicine, and 2 Vascular Research Division, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115; and 3 Department of Physiology, University of Michigan, Ann Arbor, Michigan 48109
Inhibitory
G
i protein increases in the myocardium during
hypertrophy and has been associated with
-adrenergic receptor (
-AR) desensitization, contractile dysfunction, and progression of
cardiac disease. The role of G
i proteins in mediating
basal cardiac function and
-AR response in nonpathological
myocardium, however, is uncertain. Transgenic mice with targeted
inactivation of G
i2 or G
i3 were examined
for in vivo cardiac function with the use of conscious echocardiography
and for ex vivo cardiac response to inotropic stimulation with the use
of Langendorff blood-perfused isolated hearts and adult ventricular
cardiomyocytes. Echocardiography revealed that percent fractional
shortening and heart rate were similar among wild-type,
G
i2-null, and
G
i3-null mice. Comparable baseline
diastolic and contractile performance was also observed in isolated
hearts and isolated ventricular myocytes from wild-type mice and mice
lacking G
i proteins. Isoproterenol infusion enhanced
diastolic and contractile performance to a similar degree in wild-type,
G
i2-null, and
G
i3-null mice. These data demonstrate no
observable role for inhibitory G proteins in mediating basal cardiac
function or sensitivity to
-AR stimulation in nonpathological myocardium.
Gi protein;
-adrenergic receptor sensitivity; echocardiography; isolated hearts; myocytes
This article has been cited by other articles:
![]() |
I. Luptak, J. Yan, L. Cui, M. Jain, R. Liao, and R. Tian Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress Circulation, August 21, 2007; 116(8): 901 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruan, S. Mitchell, M. Vainoriene, Q. Lou, L.-H. Xie, S. Ren, J. I. Goldhaber, and Y. Wang Gi{alpha}1-Mediated Cardiac Electrophysiological Remodeling and Arrhythmia in Hypertrophic Cardiomyopathy Circulation, August 7, 2007; 116(6): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, D. A. Brenner, L. Cui, C. C. Lim, B. Wang, D. R. Pimentel, S. Koh, D. B. Sawyer, J. A. Leopold, D. E. Handy, et al. Glucose-6-Phosphate Dehydrogenase Modulates Cytosolic Redox Status and Contractile Phenotype in Adult Cardiomyocytes Circ. Res., July 25, 2003; 93 (2): e9 - e16. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liao, M. Jain, L. Cui, J. D'Agostino, F. Aiello, I. Luptak, S. Ngoy, R. M. Mortensen, and R. Tian Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice Circulation, October 15, 2002; 106(16): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Kilts, T. Akazawa, M. D. Richardson, and M. M. Kwatra Age Increases Cardiac Galpha i2 Expression, Resulting in Enhanced Coupling to G Protein-coupled Receptors J. Biol. Chem., August 16, 2002; 277(34): 31257 - 31262. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |